Key result
Clinically relevant depressive symptoms were associated with a 27% increased risk of new cardiovascular disease diagnosis over 18 years of follow-up (HR 1.27; 95% CI 1.17-1.39).
Why the study?
Do clinically relevant depressive symptoms increase the risk of new cardiovascular disease in middle-aged and older adults?
Cohort (n=8,597)
Yes
Do clinically relevant depressive symptoms increase the risk of new cardiovascular disease in middle-aged and older adults?
Effect estimate: HR 1.27 (95% CI 1.17-1.39)
Clinically relevant depressive symptoms are associated with a 27% increased risk of incident cardiovascular disease over 18 years in middle-aged and older US adults.
Depressive symptoms merit inclusion in CVD risk stratification; extends prior observational links but leaves causal effects and intervention benefits open.
OBJECTIVES: To examine the relationship between depression and onset of cardiovascular disease (CVD) among the US middle-aged and older adults. METHODS: The study sample came from 1992-2010 waves of the Health and Retirement Study, a nationally representative longitudinal survey, consisting of 8597 community-dwelling adults aged 51-61 years old in 1992 with no CVD history. A score of ≥3 on the 8-item Center for Epidemiologic Studies Depression Scale was used to define clinically relevant depressive symptoms. Kaplan-Meier estimator and Cox proportional hazards model were performed to examine the association between baseline depressive symptoms and future CVD event. Subgroup analyses were conducted by sex and race/ethnicity. RESULTS: Compared with their counterparts without clinically relevant depressive symptoms, adults with clinically relevant depressive symptoms in 1992 were 27% (hazard ratio [HR] = 1.27, 95% confidence interval = 1.17-1.39) more likely to report new diagnosis of CVD during the 18 years of follow-up. A significant dose-response relationship was present between severity of depressive symptoms and elevated CVD risk. The adjusted HRs for males and Hispanics appeared moderately larger than for their female and non-Hispanic white or African American counterparts, although the differences were not statistically significant. CONCLUSION: Holistic promotion of mental health through prevention, education, treatment, and rehabilitation is warranted to reduce CVD risk in the US middle-aged and older population.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2015) conducted a cohort in Depression and cardiovascular disease (n=8,597). Clinically relevant depressive symptoms vs. No clinically relevant depressive symptoms was evaluated on New diagnosis of CVD (HR 1.27, 95% CI 1.17-1.39). Clinically relevant depressive symptoms were associated with a 27% increased risk of new cardiovascular disease diagnosis over 18 years of follow-up (HR 1.27; 95% CI 1.17-1.39).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: